Inventor · disambiguated record
Norio Hamamatsu
Also filed as: HAMAMATSU NORIO
11 granted patents·4 pending applications·149 citations·filing 1999–2021
90Inventor score
Top patents by PatentIndex Score
15 records- 0195US9006400B2Fibroblast growth factor-21-Fc fusion proteinsBOETTCHER BRIAN R·Filed 2012·Granted Apr 14, 2015·62 cites·7 claims
- 0293US9023791B2Fibroblast growth factor 21 mutationsBOETTCHER BRIAN R·Filed 2011·Granted May 5, 2015·37 cites·39 claims
- 0392US9266935B2Methods of treating metabolic disorders with an FGF21 variantBOETTCHER BRIAN R·Filed 2015·Granted Feb 23, 2016·14 cites·23 claims
- 0488US10669323B2Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteinsBOETTCHER BRIAN R·Filed 2016·Granted Jun 2, 2020·5 cites·15 claims
- 0588US9458214B2Dual function fibroblast growth factor 21 proteinsNOVARTIS AG·Filed 2012·Granted Oct 4, 2016·15 cites·16 claims
- 0687US10076554B2FGF21-FC fusion proteins for treating metabolic disordersNOVARTIS AG·Filed 2016·Granted Sep 18, 2018·5 cites·35 claims
- 0784US11129874B2Nucleic acids encoding FGF21-Fc fusion proteinsNOVARTIS AG·Filed 2018·Granted Sep 28, 2021·3 cites·12 claims
- 0877US11944664B2Fibroblast growth factor-21-Fc fusion proteinsNOVARTIS AG·Filed 2021·Granted Apr 2, 2024·0 cites·9 claims
- 0973US7037698B2Pyrroloquinoline quinone-dependent glucose dehydrogenaseAMANO ENZYME INC·Filed 2004·Granted May 2, 2006·5 cites·5 claims
- 1053US2020181216A1Hsa-gdf-15 fusion polypeptide and use thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1150US2008152738A1Formulations useful for immunotherapy for cancers containing bacterial component as an active ingredientDAINIPPON SUMITOMO PHARMA CO·Filed 2007·Application pending·0 cites
- 1240US2017204149A1Hsa-gdf-15 fusion polypeptide and use thereofCHOPRA RAJIV·Filed 2015·Application pending·0 cites
- 1339US2016051628A1Methods of treating fgf21-associated disordersBOETTCHER BRIAN R·Filed 2015·Application pending·0 cites
- 1435US11312766B2Antibodies against growth differentiation factor 15 and uses thereofNOVARTIS AG·Filed 2017·Granted Apr 26, 2022·0 cites·20 claims
- 1534US7534443B1Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredientAZUMA ICHIRO·Filed 1999·Granted May 19, 2009·3 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Norio Hamamatsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →